ECI is a biopharma company dedicated to the development, commercialization, and marketing of specialty human plasma/serum-derived drugs for ophthalmic conditions; wound healing; and burns. Leveraging a novel molecule to enhance consistency, and decrease the risk of pathogenicity, ECI seeks to harness the power of blood to heal.
Company Details
- Employees
- 5
- Address
- 700 Main St, Cambridge,massachusetts 02139,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.ecitherapeutics.com/
- HQ
- Cambridge, Massachusetts
Eci Therapeutics Questions
Eci Therapeutics's website is http://www.ecitherapeutics.com/
Eci Therapeutics's LinkedIn profile is https://www.linkedin.com/company/eci-therapeutics
Eci Therapeutics has
5 employees.
View email and phone details for 5
employees at Eci Therapeutics.
Eci Therapeutics's industry is
Biotechnology Research
Eci Therapeutics's top competitors are
Fletcher Biosciences,
Gelmedix,
Netzsch Instruments North America L.l.c.,
Pearl Bio,
Vertex Pharmaceuticals,
Cerberus Therapeutics,
Dacapo Brainscience,
Ocular Therapeutix, Inc.,
Cerus,
Jorna Therapeutics.
Eci Therapeutics's categories are Biotechnology Research
